Min Shi

11.2k total citations · 2 hit papers
204 papers, 7.9k citations indexed

About

Min Shi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Min Shi has authored 204 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 50 papers in Cancer Research and 43 papers in Oncology. Recurrent topics in Min Shi's work include MicroRNA in disease regulation (26 papers), Cancer-related molecular mechanisms research (23 papers) and Gastric Cancer Management and Outcomes (19 papers). Min Shi is often cited by papers focused on MicroRNA in disease regulation (26 papers), Cancer-related molecular mechanisms research (23 papers) and Gastric Cancer Management and Outcomes (19 papers). Min Shi collaborates with scholars based in China, United States and Canada. Min Shi's co-authors include Mingxin Ye, Jianfeng Shen, Yizhe Hu, Hongwei Ma, Bo Yan, Na Li, Qin Chen, Chen Li, Xin Lü and Na Li and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Min Shi

193 papers receiving 7.8k citations

Hit Papers

Fast and Facile Preparation of Graphene Oxide and Reduced... 2009 2026 2014 2020 2009 2011 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Shi China 45 2.7k 2.4k 2.0k 1.7k 1.3k 204 7.9k
Jun Zhao China 44 1.7k 0.6× 1.4k 0.6× 1.1k 0.6× 901 0.5× 940 0.7× 256 6.4k
Wei Liu China 56 3.4k 1.3× 2.9k 1.2× 6.0k 3.1× 597 0.3× 1.5k 1.2× 280 11.1k
Yin Wang China 48 2.8k 1.1× 1.5k 0.6× 2.0k 1.0× 734 0.4× 473 0.4× 248 8.3k
Hui Gao China 52 2.5k 1.0× 1.9k 0.8× 2.1k 1.1× 879 0.5× 460 0.4× 348 8.8k
Qi Lei China 50 2.4k 0.9× 3.8k 1.6× 4.6k 2.4× 510 0.3× 651 0.5× 144 8.8k
Jing Li China 51 3.0k 1.1× 1.6k 0.7× 3.4k 1.7× 749 0.4× 257 0.2× 226 8.6k
Bo Lei China 52 2.2k 0.8× 1.8k 0.7× 4.4k 2.3× 637 0.4× 727 0.6× 235 10.2k
Suping Li China 35 3.7k 1.4× 651 0.3× 2.0k 1.0× 1.3k 0.8× 523 0.4× 162 6.5k
Zhong Luo China 62 3.5k 1.3× 4.2k 1.7× 6.6k 3.3× 1.3k 0.7× 319 0.2× 224 12.3k
Xiaolin Li China 43 1.5k 0.6× 942 0.4× 1.5k 0.8× 783 0.5× 994 0.8× 175 6.2k

Countries citing papers authored by Min Shi

Since Specialization
Citations

This map shows the geographic impact of Min Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Shi more than expected).

Fields of papers citing papers by Min Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Shi. The network helps show where Min Shi may publish in the future.

Co-authorship network of co-authors of Min Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Min Shi. A scholar is included among the top collaborators of Min Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Shi. Min Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiaonan, Min Shi, Chenyi Liao, et al.. (2025). Ultrathin membranes prepared through interfacial polymer cross-linking for selective and fast ion transport. 2(6). 369–378. 3 indexed citations
2.
Shi, R., Qiong Wu, Jinlu Han, et al.. (2025). Biomineralized Cu-Disulfiram nanoparticles Potentiate Colorectal cancer immunotherapy through synergistic cuproptosis and apoptosis. Materials & Design. 260. 115070–115070.
3.
Shi, Min, et al.. (2025). Design, synthesis, and Biological evaluation of novel macrocyclic derivatives as potent ATP-citrate lyase inhibitors. European Journal of Medicinal Chemistry. 292. 117684–117684. 1 indexed citations
4.
Zhu, Zhenhua, Jingyi Zhou, Min Shi, et al.. (2024). Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance. Translational Oncology. 49. 102091–102091. 7 indexed citations
5.
Huang, Jianjian, Jie Chen, Min Shi, et al.. (2024). Genome assembly provides insights into the genome evolution of Baccaurea ramiflora Lour.. Scientific Reports. 14(1). 4867–4867. 1 indexed citations
6.
Yang, Lin, Xiaoping Wang, Jingjing He, et al.. (2024). Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance. Lupus Science & Medicine. 11(1). e001072–e001072. 7 indexed citations
7.
Wu, Bingbing, Yang Liu, Bo Wang, et al.. (2023). Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma. Frontiers in Neurology. 14. 1054686–1054686. 3 indexed citations
8.
Shi, Min, Jin‐Ye Wang, Jiapeng Li, et al.. (2023). TiO2-MXene/PEDOT:PSS Composite as a Novel Electrochemical Sensing Platform for Sensitive Detection of Baicalein. Molecules. 28(7). 3262–3262. 9 indexed citations
9.
Zhang, Qinghui, Rongrong Jia, Minjie Chen, et al.. (2023). Antagonizing EZH2 combined with vitamin D3 exerts a synergistic role in anti‐fibrosis through bidirectional effects on hepatocytes and hepatic stellate cells. Journal of Gastroenterology and Hepatology. 38(3). 441–450. 6 indexed citations
10.
Shi, Min, Guanwei Peng, Jingkun Xu, et al.. (2023). Electrochemical determination of benomyl using MWCNTs interspersed graphdiyne as enhanced electrocatalyst. Microchimica Acta. 190(3). 98–98. 5 indexed citations
11.
Shi, Min, Jing Yang, Yongfang Yu, et al.. (2021). MXene/carbon nanohorns decorated with conductive molecularly imprinted poly(hydroxymethyl-3,4-ethylenedioxythiophene) for voltammetric detection of adrenaline. Microchimica Acta. 188(12). 420–420. 25 indexed citations
12.
Zhao, Jiawei, Yugang Wang, Wenjing Wang, et al.. (2021). In situ growth of nano-antioxidants on cellular vesicles for efficient reactive oxygen species elimination in acute inflammatory diseases. Nano Today. 40. 101282–101282. 36 indexed citations
13.
Shi, Min, Zhenglun Zhu, Hong Yuan, et al.. (2021). Addition of Sintilimab to Nanoparticle Albumin-Bound Paclitaxel and S-1 as Adjuvant Therapy in Stage IIIC Gastric Cancer. Future Oncology. 18(2). 139–148. 6 indexed citations
14.
Sah, Birendra Kumar, Benyan Zhang, Huan Zhang, et al.. (2020). Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer. Nature Communications. 11(1). 6093–6093. 72 indexed citations
15.
Shi, Min, Jun Zhang, & Zhenggang Zhu. (2018). [Therapeutic arrangement and strategies in perioperative treatment of locally advanced gastric cancer from the view of whole-process management].. PubMed. 21(10). 1093–1098. 1 indexed citations
16.
Shi, Min, Jingjin Zhao, Shuting Li, Jianniao Tian, & Shulin Zhao. (2018). A novel chemiluminescence signal amplification strategy based on a capillary electrophoresis platform for highly sensitive competitive immunoassay of biomolecules. Analytical Methods. 10(46). 5499–5506. 2 indexed citations
19.
Cui, Jiujie, Min Shi, Dacheng Xie, et al.. (2014). FOXM1 Promotes the Warburg Effect and Pancreatic Cancer Progression via Transactivation of LDHA Expression. Clinical Cancer Research. 20(10). 2595–2606. 197 indexed citations
20.
Shi, Min, Jiujie Cui, Jiawei Du, et al.. (2014). A Novel KLF4/LDHA Signaling Pathway Regulates Aerobic Glycolysis in and Progression of Pancreatic Cancer. Clinical Cancer Research. 20(16). 4370–4380. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026